XML 23 R12.htm IDEA: XBRL DOCUMENT
v3.23.2

Loss Per Share | 6 Months Ended
--- | ---
Jul. 28, 2023
Earnings Per Share [Abstract] |
Loss Per Share | NOTE 3. LOSS PER SHARE The numerator for both basic and diluted EPS is net loss. The denominator for basic EPS is based upon the number of weighted average shares of Lands’ End common stock outstanding during the reporting periods. The denominator for diluted EPS is based upon the number of weighted average shares of Lands’ End common stock and common stock equivalents outstanding during the reporting periods using the treasury stock method in accordance with GAAP. Potentially dilutive securities for the diluted EPS calculations consist of non-vested equity shares of common stock and in-the-money outstanding options where the current stock price exceeds the option strike price. The following table summarizes the components of basic and diluted EPS:
|  | 13 Weeks Ended |  |  | 26 Weeks Ended |
(in thousands, except per share amounts) |  | July 28, 2023 |  |  | July 29, 2022 |  |  | July 28, 2023 |  |  | July 29, 2022 |
Net loss |  | $ | (8,018 | ) |  | $ | (2,179 | ) |  | $ | (9,670 | ) |  | $ | (4,550 | )
Basic weighted average common shares outstanding |  |  | 32,117 |  |  |  | 33,361 |  |  |  | 32,280 |  |  |  | 33,262 |
Dilutive effect of stock awards |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |
Diluted weighted average common shares outstanding |  |  | 32,117 |  |  |  | 33,361 |  |  |  | 32,280 |  |  |  | 33,262 |
Basic loss per share |  | $ | (0.25 | ) |  | $ | (0.07 | ) |  | $ | (0.30 | ) |  | $ | (0.14 | )
Diluted loss per share |  | $ | (0.25 | ) |  | $ | (0.07 | ) |  | $ | (0.30 | ) |  | $ | (0.14 | )
Stock awards are considered anti-dilutive based on the application of the treasury stock method or in the event of a net loss. Anti-dilutive shares excluded from the diluted weighted average shares outstanding were 1,617,940 anti-dilutive shares in the 13 weeks ended July 28, 2023, 1,098,859 anti-dilutive shares in the 13 weeks ended July 29, 2022, 1,411,376 anti-dilutive shares in the 26 weeks ended July 28, 2023 and 1,209,586 anti-dilutive shares in the 26 weeks ended July 29, 2022.

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for earnings per share. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org//260/tableOfContent Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482662/260-10-50-2 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482662/260-10-50-3 + Details
Name: | us-gaap_EarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration